APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. (Q38406031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Jin Joo Cha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Hye Sook Min

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Ki Tae Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Jung Eun Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Jung Yeon Ghee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Hyun Wook Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Ji Eun Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Jee Young Han

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Gayoung Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Yun Soo Bae

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sae Rom Lee

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sung Hwan Moon

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Sung Chan Lee

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Ganghyun Kim

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Young Sun Kang

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Dae Ryong Cha

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

6 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

419-431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28165467%20AND%20SRC:MED&resulttype=core&format=json

Regulation of reactive oxygen species generation in cell signaling

1 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Oxidative stress and organ damages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Nox as a target for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Improved methods for culturing rat glomerular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Oxidant Mechanisms in Renal Injury and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Are reactive oxygen species still the basis for diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

21 January 2018

Nox and renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidase 5 and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Role of Nox2 in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Role of Nox4 in murine models of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Endotoxemia in end-stage kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Probucol inhibited Nox2 expression and attenuated podocyte injury in type 2 diabetic nephropathy of db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Obesity-induced inflammation: a metabolic dialogue in the language of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Nox4 acts as a switch between differentiation and proliferation in preadipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2

Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.2